PAR1 antagonists (Pierre Fabre)

N/A

Report date: 2025/06/11 10:42:55
NME

Base Information

Drug NamePAR1 antagonists (Pierre Fabre)
Drug Alias Nameprotease-activated receptor-1 antagonists (Pierre Fabre)F-16357F-16618
ClassificationSmall molecules
Mechanisms of ActionProtease-activated receptor-1 antagonistsFibrinolysis stimulants
TargetsProtease-activated receptor-1
Therapy Area/IndicationsThrombosisCoronary RestenosisUrinary Bladder Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPierre Fabre Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPierre Fabre Ltd
Inactive CompaniesN/A
Active IndicationsThrombosisCoronary RestenosisUrinary Bladder Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A